Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study Prepared Remarks Transcript

▶ Seeking Alpha Aug 6, 2026 11h ago 👁 1 views

📋 Article Summary

11 words

Read the full story on Seeking Alpha via the link below.

ⓘ Summary only. Read the complete story on Seeking Alpha below.

Full story on Seeking Alpha

🔗 You will be taken to seekingalpha.com

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.